#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Dyadic strengthens European leadership team

Share on Twitter Share on LinkedIn
Staff writer | Jupiter, Fla., USA | May 7, 2014
DyadicMay 7, 2014, Jupiter, Fla., USA - Dyadic International, Inc., a global biotechnology company, announced that they have strengthened their European leadership team with the addition of two senior level positions.
Ronen Tchelet has joined the Company's European leadership team as the Vice President of Business Development.

Dr. Tchelet joins Dyadic from Codexis, where he served as Vice President and Managing Director of their Research and Development laboratories in Hungary. Prior to Codexis, Dr. Tchelet served as Chief Technology Officer of Biotechnology for the API division of Teva Pharmaceuticals.

Dyadic also announces that next month Andre Klaassen will be joining Dyadic's European sales team as the new Director of Sales for Europe.

Mr. Klaassen has spent the past two decades in enzyme sales at DuPont and Genencor in a variety of senior roles. He began his career in engineering and operational roles at Gist-Brocades, now part of DSM. In addition, Mr. Klaassen will provide key account management, and assume global responsibility for our starch and alcohol enzyme business.